Clinical Trials are available to all patients with a diagnosis of cancer, if they meet eligibility requirements for specific trials. Kent Hospital Clinical Trials program participates in clinical trials through an affiliation with the American College of Surgeons Oncology Group utilizing the Cancer Trials Support Unit (CTSU). The CTSU is a project sponsored by the National Cancer Institute (NCI) for the support of a national network of physicians to participate in the NCI sponsored Phase III cancer treatment trials. For more information regarding participation in a clinical research trial, please call the Cancer Registry/Protocol office at 401-737-7010, extension 31503.
Kent Hospital's Cancer Program participates in a number of clinical research trials through the Cancer Registry, offering cutting edge treatments to our patients. The Cancer Registry maintains a data base, allowing us to track disease characteristics and treatments. Our program is accredited with commendation by the American College of Surgeons Commission on Cancer, as a Community Hospital Cancer Program. For further information on accreditation and how it benefits our cancer program, please access the COC link at http://www.facs.org/cancer/coc/benefitsofcoc.html.